Discover the future of targeted anticancer therapies at the ESMO Targeted Anticancer Therapies Congress. Known as 'The Home of Phase I in Oncology,' this event offers participants a unique opportunity to explore promising new anticancer targets and agents. With a particular focus on those in early phase clinical development, this congress provides a glimpse into the cutting-edge advancements in the field.

At the ESMO TAT Congress, stakeholders from academia and industry come together to engage in discussions with clinicians, researchers, and regulators. This collaborative environment fosters the global dissemination of knowledge and clinical research expertise in innovative cancer therapeutics. By sharing insights and experiences, participants contribute to the advancement of cancer treatment and ultimately benefit cancer patients worldwide.

Join us in the beautiful city of Paris, France, for this influential event. Immerse yourself in the latest discoveries and breakthroughs in targeted anticancer therapies. Connect with experts in the field and gain valuable insights that can shape the future of cancer treatment. Don't miss your chance to be a part of this transformative congress.